Significant Ownership of NORTHSTRIVE FUND II LP

Manager identity
Signature and title
/s/ Braeden Lichti - Braeden Lichti/Manager
Location
Newport Beach, CA
Large-stake snapshot
Schedule 13D/G read
Recent SEC Schedule 13D/G filings for NORTHSTRIVE FUND II LP, focused on large-stake beneficial ownership disclosures and amendments.

Follow Filing Activity

Follow NORTHSTRIVE FUND II LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of NORTHSTRIVE FUND II LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NVNO enVVeno Medical Corp Common Stock, par value $0.00001 per share 5% $331,842 33,151 0% Braeden Lichti 20 Feb 2026
BJDX Bluejay Diagnostics, Inc. Common Stock, par value $0.0001 per share 3.6% $115,375 35,500 0% Braeden Lichti 11 Mar 2026
ENVB ENVERIC BIOSCIENCES, INC. Common Stock, $0.01 par value per share 0% $0 -$163,363 0 -100% Northstrive Fund II LP 09 Dec 2025

Schedules 13D/G Reported by NORTHSTRIVE FUND II LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
An asterisk next to the price means the reported price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .